BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 898 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $409,310 | -94.2% | 12,233 | -92.5% | 0.01% | -94.3% |
| Q1 2024 | $7,014,185 | +2198.2% | 164,110 | +1979.7% | 0.17% | +1350.0% |
| Q4 2023 | $305,199 | -14.5% | 7,891 | -16.5% | 0.01% | -25.0% |
| Q3 2023 | $356,836 | -49.8% | 9,455 | -39.4% | 0.02% | -51.5% |
| Q2 2023 | $710,829 | -12.1% | 15,602 | +54.8% | 0.03% | -68.6% |
| Q4 2020 | $809,000 | +0.1% | 10,080 | +0.3% | 0.10% | -17.3% |
| Q3 2020 | $808,000 | +6.3% | 10,053 | +13.9% | 0.13% | -2.3% |
| Q2 2020 | $760,000 | +6.3% | 8,827 | +0.3% | 0.13% | -16.7% |
| Q1 2020 | $715,000 | -5.8% | 8,804 | -3.1% | 0.16% | +27.9% |
| Q4 2019 | $759,000 | -4.2% | 9,082 | +0.3% | 0.12% | -10.3% |
| Q3 2019 | $792,000 | +10.8% | 9,059 | +3.7% | 0.14% | -0.7% |
| Q2 2019 | $715,000 | +0.1% | 8,735 | -0.6% | 0.14% | -3.5% |
| Q1 2019 | $714,000 | +6.9% | 8,786 | +1.3% | 0.14% | -6.0% |
| Q4 2018 | $668,000 | 0.0% | 8,671 | 0.0% | 0.15% | +0.7% |
| Q3 2018 | $668,000 | +29.2% | 8,671 | +23.9% | 0.15% | +4.2% |
| Q2 2018 | $517,000 | – | 7,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |